{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:01:41Z","timestamp":1792234901606,"version":"4.4.0"},"reference-count":155,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.pharmthera.2007.03.015","type":"journal-article","created":{"date-parts":[[2007,5,9]],"date-time":"2007-05-09T11:04:39Z","timestamp":1178708679000},"page":"13-24","source":"Crossref","is-referenced-by-count":209,"title":["Reactive carbonyls and oxidative stress: Potential for therapeutic intervention"],"prefix":"10.1016","volume":"115","author":[{"given":"Elizabeth M.","family":"Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pharmthera.2007.03.015_bib1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0006-2952(99)00132-X","article-title":"Accumulation of alpha-oxoaldehydes during oxidative stress: a role in cytotoxicity","volume":"58","author":"Abordo","year":"1999","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1471-4159.2004.02864.x","article-title":"Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment","volume":"92","author":"Ahmed","year":"2005","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0891-5849(01)00550-0","article-title":"Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cells","volume":"31","author":"Akhand","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib4","first-page":"177","volume":"Vol. 24 (4-5)","author":"Alary","year":"2003"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib5","doi-asserted-by":"crossref","unstructured":"Aldini, G., Dalle-Donne, I., Facino, R. M., Milzani, A., & Carini, M. (in press). Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med Res Rev. doi:10.1002\/med.20073","DOI":"10.1002\/med.20073"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib6","first-page":"118","volume":"vol. 12","author":"Amunom","year":"2005"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.freeradbiomed.2006.03.011","article-title":"Circulating 4-hydroxynonenal-protein thioether adducts assessed by gas chromatography-mass spectrometry are increased with disease progression and aging in spontaneously hypertensive rats","volume":"41","author":"Asselin","year":"2006","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.03.015_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-1218(94)90035-3","article-title":"Acrolein genotoxicity in Drosophila melanogaster: III. Effects of metabolism modification","volume":"321","author":"Barros","year":"1994","journal-title":"Mutat Res"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.03.015_bib9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2337\/diacare.24.4.726","article-title":"alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia","volume":"24","author":"Beisswenger","year":"2001","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0005-2760(80)90209-X","article-title":"Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids","volume":"620","author":"Benedetti","year":"1980","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib11","first-page":"6120","volume":"Vol. 61 (16)","author":"Bonnesen","year":"2001"},{"issue":"9","key":"10.1016\/j.pharmthera.2007.03.015_bib12","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.cub.2004.04.036","article-title":"The Drosophila carbonyl reductase sniffer prevents oxidative stress-induced neurodegeneration","volume":"14","author":"Botella","year":"2004","journal-title":"Curr Biol"},{"issue":"Pt 6","key":"10.1016\/j.pharmthera.2007.03.015_bib13","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1042\/bst0311400","article-title":"Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus","volume":"31","author":"Bourajjaj","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0165-1218(86)90051-0","article-title":"Cytotoxicity, DNA fragmentation and sister-chromatid exchange in Chinese hamster ovary cells exposed to the lipid peroxidation product 4-hydroxynonenal and homologous aldehydes","volume":"171","author":"Brambilla","year":"1986","journal-title":"Mutat Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1179\/rer.2000.5.1.47","article-title":"The antihypertensive hydralazine is an efficient scavenger of acrolein","volume":"5","author":"Burcham","year":"2000","journal-title":"Redox Rep"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.03.015_bib16","first-page":"607","article-title":"Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase","volume":"59","author":"Burczynski","year":"1999","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.03.015_bib17","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1074\/jbc.M006655200","article-title":"The reactive oxygen species- and Michael acceptor inducible human aldo-keto reductase AKR1C1 reduces the alpha-beta unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene","volume":"276","author":"Burczynski","year":"2001","journal-title":"J Biol Chem"},{"issue":"14","key":"10.1016\/j.pharmthera.2007.03.015_bib18","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1096\/fasebj.10.14.9002551","article-title":"Osmotic regulation of gene expression","volume":"10","author":"Burg","year":"1996","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1046\/j.1471-4159.1999.0720751.x","article-title":"Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease","volume":"72","author":"Calingasan","year":"1999","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1385\/CT:3:2:165","article-title":"The role of chemically induced glutathione and glutathione S-transferase in protecting against 4-hydroxy-2-nonenal-mediated cytotoxicity in vascular smooth muscle cells","volume":"3","author":"Cao","year":"2003","journal-title":"Cardiovasc Toxicol"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0021-9150(02)00331-3","article-title":"Induction of cellular glutathione and glutathione S-transferase by 3H-1,2-dithiole-3-thione in rat aortic smooth muscle A10 cells: protection against acrolein-induced toxicity","volume":"166","author":"Cao","year":"2003","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.pharmthera.2007.03.015_bib22","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1177\/153537020623100809","article-title":"Antioxidants and phase 2 enzymes in cardiomyocytes: chemical inducibility and chemoprotection against oxidant and simulated ischemia\u2013reperfusion injury","volume":"231","author":"Cao","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.03.015_bib23","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.ATV.0000122852.22604.78","article-title":"Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited","volume":"24","author":"Ceriello","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Pt 2","key":"10.1016\/j.pharmthera.2007.03.015_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/bj20020320","article-title":"Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice","volume":"365","author":"Chanas","year":"2002","journal-title":"Biochem J"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.03.015_bib25","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1124\/mol.61.5.1184","article-title":"Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes","volume":"61","author":"Chang","year":"2002","journal-title":"Mol Pharmacol"},{"issue":"8","key":"10.1016\/j.pharmthera.2007.03.015_bib26","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2174\/1381612043452901","article-title":"Induction of cytoprotective genes through Nrf2\/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases","volume":"10","author":"Chen","year":"2004","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/abbi.2001.2452","article-title":"Transfection of mGSTA4 in HL-60 cells protects against 4-hydroxynonenal-induced apoptosis by inhibiting JNK-mediated signaling","volume":"392","author":"Cheng","year":"2001","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.03.015_bib28","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/hep.510290510","article-title":"Regulation of rat hepatocyte protein kinase C beta isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal: a signaling pathway to modulate vesicular transport of glycoproteins","volume":"29","author":"Chiarpotto","year":"1999","journal-title":"Hepatology"},{"issue":"1-2","key":"10.1016\/j.pharmthera.2007.03.015_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/ars.2006.8.76","article-title":"Nrf2 defends the lung from oxidative stress","volume":"8","author":"Cho","year":"2006","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.03.015_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/em.2860090308","article-title":"Mutagenicity and toxicity studies of several alpha,beta-unsaturated aldehydes in the Salmonella typhimurium mutagenicity assay","volume":"9","author":"Cooper","year":"1987","journal-title":"Environ Mutagen"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.03.015_bib31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.freeradbiomed.2005.09.038","article-title":"Carbonyl stress and NMDA receptor activation contribute to methylglyoxal neurotoxicity","volume":"40","author":"de Arriba","year":"2006","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"10.1016\/j.pharmthera.2007.03.015_bib32","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1074\/jbc.M312062200","article-title":"Fatty aldehyde dehydrogenase: potential role in oxidative stress protection and regulation of its gene expression by insulin","volume":"279","author":"Demozay","year":"2004","journal-title":"J Biol Chem"},{"issue":"44","key":"10.1016\/j.pharmthera.2007.03.015_bib154","doi-asserted-by":"crossref","first-page":"40803","DOI":"10.1074\/jbc.M105487200","article-title":"Antioxidative function and substrate specificity of NAD(P)H-dependent alkenal\/one oxidoreductase. A new role for leukotriene B4 12-hydroxydehydrogenase\/15-oxoprostaglandin 13-reductase","volume":"276","author":"Dick","year":"2001","journal-title":"J Biol Chem"},{"issue":"41","key":"10.1016\/j.pharmthera.2007.03.015_bib33","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1021\/bi049136q","article-title":"Human carbonyl reductase catalyzes reduction of 4-oxonon-2-enal","volume":"43","author":"Doorn","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib34","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1093\/emboj\/cdg412","article-title":"A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling","volume":"22","author":"Echtay","year":"2003","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0027-5107(93)90158-C","article-title":"Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes","volume":"290","author":"Eckl","year":"1993","journal-title":"Mutat Res"},{"issue":"2-3","key":"10.1016\/j.pharmthera.2007.03.015_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.alcalc.a044985","article-title":"Alcohol and aldehyde dehydrogenase","volume":"25","author":"Ehrig","year":"1990","journal-title":"Alcohol Alcohol"},{"issue":"Pt2","key":"10.1016\/j.pharmthera.2007.03.015_bib37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/bj3120535","article-title":"Substrate-specificity of an aflatoxin-metabolizing aldehyde reductase","volume":"312","author":"Ellis","year":"1995","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib38","doi-asserted-by":"crossref","first-page":"10350","DOI":"10.1073\/pnas.90.21.10350","article-title":"An ethoxyquin-inducible aldehyde reductase from rat liver that metabolises aflatoxin B1 defines a subfammily of aldo-keto reductases","volume":"90","author":"Ellis","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.03.015_bib39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/carcin\/bgg016","article-title":"Characterization of the rat aflatoxin B(1) aldehyde reductase gene, AKR7A1. Structure and chromosomal localization of AKR7A1 as well as identification of antioxidant response elements in the gene promoter","volume":"24","author":"Ellis","year":"2003","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.03.015_bib42","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1515\/znc-1975-7-808","article-title":"Reaction of glutathione with conjugated carbonyls","volume":"30","author":"Esterbauer","year":"1975","journal-title":"Z Naturforsch C"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj2080129","article-title":"Separation and characterization of the aldehydic products of lipid peroxidation stimulated by ADP-Fe2+ in rat liver microsomes","volume":"208","author":"Esterbauer","year":"1982","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.exer.2006.04.010","article-title":"ALDH3A1: a corneal crystallin with diverse functions","volume":"84","author":"Estey","year":"2007","journal-title":"Exp Eye Res"},{"issue":"17","key":"10.1016\/j.pharmthera.2007.03.015_bib44","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/0006-2952(82)90123-X","article-title":"Aldehyde reductases: monomeric NADPH-dependent oxidoreductases with multifunctional potential","volume":"31","author":"Flynn","year":"1982","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.pharmthera.2007.03.015_bib45","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bcp.2006.02.018","article-title":"Several glutathione S-transferase isozymes that protect against oxidative injury are expressed in human liver mitochondria","volume":"71","author":"Gallagher","year":"2006","journal-title":"Biochem Pharmacol"},{"issue":"26","key":"10.1016\/j.pharmthera.2007.03.015_bib46","doi-asserted-by":"crossref","first-page":"15221","DOI":"10.1073\/pnas.261572998","article-title":"Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: the indirect antioxidant effects of sulforaphane","volume":"98","author":"Gao","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1-2","key":"10.1016\/j.pharmthera.2007.03.015_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ymgme.2006.05.009","article-title":"Bezafibrate induces FALDH in human fibroblasts; implications for Sjogren-Larsson syndrome","volume":"89","author":"Gloerich","year":"2006","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/taap.1993.1058","article-title":"Activity of mouse liver glutathione S-transferases toward trans,trans-muconaldehyde and trans-4-hydroxy-2-nonenal","volume":"119","author":"Goon","year":"1993","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.03.015_bib49","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1021\/tx0002583","article-title":"Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity","volume":"14","author":"Guengerich","year":"2001","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib50","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-2275(20)33350-2","article-title":"In vivo involvement of cytochrome P450 4A family in the oxidative metabolism of the lipid peroxidation product trans-4-hydroxy-2-nonenal, using PPARalpha-deficient mice","volume":"40","author":"Gueraud","year":"1999","journal-title":"J Lipid Res"},{"issue":"9","key":"10.1016\/j.pharmthera.2007.03.015_bib51","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","article-title":"Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment","volume":"18","author":"Halliwell","year":"2001","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/abbi.1995.1028","article-title":"The hepatocellular metabolism of 4-hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase, and glutathione S-transferase","volume":"316","author":"Hartley","year":"1995","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0304-3835(01)00695-4","article-title":"Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention","volume":"174","author":"Hayes","year":"2001","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.03.015_bib55","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/10409239509083491","article-title":"The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance","volume":"30","author":"Hayes","year":"1995","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.pharmtox.45.120403.095857","article-title":"Glutathione transferases","volume":"45","author":"Hayes","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-5793(02)02982-4","article-title":"Characterisation of a novel mouse liver aldo-keto reductase AKR7A5","volume":"523","author":"Hinshelwood","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib57","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0009-2797(02)00173-4","article-title":"Substrate specificity of mouse aldo-keto reductase AKR7A5","volume":"143-144","author":"Hinshelwood","year":"2003","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib58","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0021-9150(97)00305-5","article-title":"Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis","volume":"137","author":"Holvoet","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2005.11.050","article-title":"Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL\/6J mice and C57BL\/6J\/Nrf2 (\u2212\/\u2212) mice","volume":"243","author":"Hu","year":"2006","journal-title":"Cancer Lett"},{"issue":"20","key":"10.1016\/j.pharmthera.2007.03.015_bib60","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.lfs.2006.06.019","article-title":"Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray","volume":"79","author":"Hu","year":"2006","journal-title":"Life Sci"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2007.03.015_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1042\/bj3300175","article-title":"Human glutathione transferase A4-4: an alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation","volume":"330","author":"Hubatsch","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib62","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0009-2797(02)00193-X","article-title":"The aldo-keto reductase superfamily homepage","volume":"143-144","author":"Hyndman","year":"2003","journal-title":"Chem-Biol Interact"},{"issue":"8","key":"10.1016\/j.pharmthera.2007.03.015_bib63","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1021\/tx000186f","article-title":"4-hydroxynonenal induces apoptosis via caspase-3 activation and cytochrome c release","volume":"14","author":"Ji","year":"2001","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev.pharmtox.47.120505.105337","article-title":"Aldo-keto reductases and bioactivation\/detoxication","volume":"47","author":"Jin","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib65","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/bbrc.2000.2923","article-title":"Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population","volume":"273","author":"Kamino","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 3","key":"10.1016\/j.pharmthera.2007.03.015_bib66","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1042\/bj2790903","article-title":"Aldehyde reductase is a major protein associated with 3-deoxyglucosone reductase activity in rat, pig and human livers","volume":"279","author":"Kanazu","year":"1991","journal-title":"Biochem J"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.03.015_bib67","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0145-2126(95)00162-X","article-title":"Effect of methylglyoxal on human leukaemia 60 cell growth: modification of DNA G1 growth arrest and induction of apoptosis","volume":"20","author":"Kang","year":"1996","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib68","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0027-5107(97)00170-X","article-title":"Cytotoxic and genotoxic effects of 4-hydroxynonenal in cerebral endothelial cells","volume":"381","author":"Karlhuber","year":"1997","journal-title":"Mutat Res"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib69","first-page":"681","article-title":"Mutagenicity of methylglyoxal in coffee","volume":"73","author":"Kasai","year":"1982","journal-title":"Gann"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.03.015_bib70","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00401-006-0044-1","article-title":"Crotonaldehyde accumulates in glial cells of Alzheimer's disease brain","volume":"111","author":"Kawaguchi-Niida","year":"2006","journal-title":"Acta Neuropathol (Berl)"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib71","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0009-2797(02)00023-6","article-title":"Expression of rat liver glutathione-S-transferase GSTA5 in cell lines provides increased resistance to alkylating agents and toxic aldehydes","volume":"140","author":"Kazi","year":"2002","journal-title":"Chem Biol Interact"},{"issue":"23","key":"10.1016\/j.pharmthera.2007.03.015_bib72","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/S0024-3205(97)00935-1","article-title":"Heterologous expression of carbonyl reductase: demonstration of prostaglandin 9-ketoreductase activity and paraquat resistance","volume":"61","author":"Kelner","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","article-title":"Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway","volume":"47","author":"Kensler","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"9","key":"10.1016\/j.pharmthera.2007.03.015_bib74","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/diacare.21.9.1414","article-title":"Global burden of diabetes, 1995\u20132025: prevalence, numerical estimates, and projections","volume":"21","author":"King","year":"1998","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib75","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.molbrainres.2004.10.006","article-title":"Protective effect of diallyl disulfide on oxidative stress-injured neuronally differentiated PC12 cells","volume":"133","author":"Koh","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"issue":"7","key":"10.1016\/j.pharmthera.2007.03.015_bib76","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bcp.2006.04.017","article-title":"Activation of coupled Ah receptor and Nrf2 gene batteries by dietary phytochemicals in relation to chemoprevention","volume":"72","author":"Kohle","year":"2006","journal-title":"Biochem Pharmacol"},{"issue":"13","key":"10.1016\/j.pharmthera.2007.03.015_bib77","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1523\/JNEUROSCI.17-13-05089.1997","article-title":"Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis","volume":"17","author":"Kruman","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib78","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1196\/annals.1333.026","article-title":"Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease","volume":"1043","author":"Kuhla","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"10.1016\/j.pharmthera.2007.03.015_bib79","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1074\/jbc.M211898200","article-title":"Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival","volume":"278","author":"Kwak","year":"2003","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.pharmthera.2007.03.015_bib80","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/mnfr.200500090","article-title":"4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis","volume":"49","author":"Leonarduzzi","year":"2005","journal-title":"Mol Nutr Food Res"},{"issue":"1-2","key":"10.1016\/j.pharmthera.2007.03.015_bib84","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1089\/ars.2006.8.88","article-title":"Role of the Nrf2-mediated signaling pathway as a negative regulator of inflammation: implications for the impact of particulate pollutants on asthma","volume":"8","author":"Li","year":"2006","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib83","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/taap.1996.0152","article-title":"4-Hydroxynonenal-induced cell death in murine alveolar macrophages","volume":"139","author":"Li","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib82","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/taap.1997.8189","article-title":"Acrolein-induced cell death in human alveolar macrophages","volume":"145","author":"Li","year":"1997","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib86","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.abb.2005.05.008","article-title":"Differential roles of 3H-1,2-dithiole-3-thione-induced glutathione, glutathione S-transferase and aldose reductase in protecting against 4-hydroxy-2-nonenal toxicity in cultured cardiomyocytes","volume":"439","author":"Li","year":"2005","journal-title":"Arch Biochem Biophys"},{"issue":"2-3","key":"10.1016\/j.pharmthera.2007.03.015_bib81","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.tox.2006.06.013","article-title":"Mouse aldo-keto reductase AKR7A5 protects V79 cells against 4-hydroxynonenal-induced apoptosis","volume":"226","author":"Li","year":"2006","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib85","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.phrs.2005.08.002","article-title":"Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress","volume":"53","author":"Li","year":"2006","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib87","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/10409239209082565","article-title":"Aldehyde dehydrogenases and their role in carcinogenesis","volume":"27","author":"Lindahl","year":"1992","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"11","key":"10.1016\/j.pharmthera.2007.03.015_bib88","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/0006-2952(91)90157-Z","article-title":"Lipid aldehyde oxidation as a physiological role for class 3 aldehyde dehydrogenases","volume":"41","author":"Lindahl","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib89","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1124\/mol.105.019794","article-title":"Induction of AKR1C2 by Phase II Inducers: Identification of a distal consensus antioxidant response element regulated by Nrf2","volume":"69","author":"Lou","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib90","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0197-4580(00)00235-9","article-title":"Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures","volume":"22","author":"Lovell","year":"2001","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.03.015_bib91","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1513\/pats.200504-045SR","article-title":"Pathogenesis of chronic obstructive pulmonary disease","volume":"2","author":"MacNee","year":"2005","journal-title":"Proc Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000150649.39934.13","article-title":"Oxidative stress and vascular disease","volume":"25","author":"Madamanchi","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.03.015_bib93","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2174\/138920006778017795","article-title":"Modulation of metabolic enzymes by dietary phytochemicals: a review of mechanisms underlying beneficial versus unfavorable effects","volume":"7","author":"Mandlekar","year":"2006","journal-title":"Curr Drug Metab"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib94","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","article-title":"Oxidative stress hypothesis in Alzheimer's disease","volume":"23","author":"Markesbery","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib95","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0027-5107(85)90204-0","article-title":"Naturally occurring carbonyl compounds are mutagens in Salmonella tester strain TA104","volume":"148","author":"Marnett","year":"1985","journal-title":"Mutat Res"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.03.015_bib96","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbrc.2005.12.113","article-title":"Neuroprotective role for carbonyl reductase?","volume":"340","author":"Maser","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib97","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0003-2697(05)80005-3","article-title":"The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene","volume":"206","author":"McLellan","year":"1992","journal-title":"Anal Biochem"},{"issue":"8","key":"10.1016\/j.pharmthera.2007.03.015_bib98","first-page":"3299","article-title":"The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes","volume":"61","author":"McMahon","year":"2001","journal-title":"Cancer Res"},{"issue":"34","key":"10.1016\/j.pharmthera.2007.03.015_bib99","doi-asserted-by":"crossref","first-page":"24756","DOI":"10.1074\/jbc.M601119200","article-title":"Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a \u201ctethering\u201d mechanism: a two-site interaction model for the Nrf2-Keap1 complex","volume":"281","author":"McMahon","year":"2006","journal-title":"J Biol Chem"},{"issue":"21","key":"10.1016\/j.pharmthera.2007.03.015_bib100","doi-asserted-by":"crossref","first-page":"20340","DOI":"10.1074\/jbc.M412081200","article-title":"Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymes","volume":"280","author":"Miao","year":"2005","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.03.015_bib101","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/10715760500072255","article-title":"Acrolein induces Hsp72 via both PKCdelta\/JNK and calcium signaling pathways in human umbilical vein endothelial cells","volume":"39","author":"Misonou","year":"2005","journal-title":"Free Radic Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.03.015_bib102","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0041-008X(87)90245-6","article-title":"The oxidation of alpha-beta unsaturated aldehydic products of lipid peroxidation by rat liver aldehyde dehydrogenases","volume":"87","author":"Mitchell","year":"1987","journal-title":"Toxicol Appl Pharmacol"},{"issue":"11","key":"10.1016\/j.pharmthera.2007.03.015_bib103","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.molmed.2004.09.003","article-title":"Nrf2-Keap1 defines a physiologically important stress response mechanism","volume":"10","author":"Motohashi","year":"2004","journal-title":"Trends Mol Med"},{"issue":"4-5","key":"10.1016\/j.pharmthera.2007.03.015_bib104","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s007020050069","article-title":"Alzheimer's disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts","volume":"105","author":"Munch","year":"1998","journal-title":"J Neural Transm"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1471-4159.2003.01839.x","article-title":"Oxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (ALDH5A)","volume":"86","author":"Murphy","year":"2003","journal-title":"J Neurochem"},{"issue":"11","key":"10.1016\/j.pharmthera.2007.03.015_bib106","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s11095-006-9099-x","article-title":"Pharmacogenomics of Phenolic Antioxidant Butylated Hydroxyanisole (BHA) in the Small Intestine and Liver of Nrf2 Knockout and C57BL\/6J Mice","volume":"23","author":"Nair","year":"2006","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib107","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1254\/jphs.FP0040404","article-title":"Transcription factor Nrf2 regulates promoter activity of mouse aldose reductase (AKR1B3) gene","volume":"97","author":"Nishinaka","year":"2005","journal-title":"J Pharmacol Sci"},{"issue":"Pt 2","key":"10.1016\/j.pharmthera.2007.03.015_bib108","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/0264-6021:3430487","article-title":"Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members","volume":"343","author":"O'Connor","year":"1999","journal-title":"Biochem J"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.03.015_bib109","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1046\/j.1471-4159.2003.01619.x","article-title":"Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells","volume":"84","author":"Ohsawa","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.pharmtox.47.120505.105316","article-title":"Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology","volume":"47","author":"Oppermann","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"9","key":"10.1016\/j.pharmthera.2007.03.015_bib110","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0891-5849(03)00070-4","article-title":"Aldh3a1 protects human corneal epithelial cells from ultraviolet- and 4-hydroxy-2-nonenal-induced oxidative damage","volume":"34","author":"Pappa","year":"2003","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib111","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/toxs.1998.2462","article-title":"Metabolism and distribution of [2,3-14C]acrolein in Sprague-Dawley rats. II. Identification of urinary and fecal metabolites","volume":"43","author":"Parent","year":"1998","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib113","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-8993(01)02897-9","article-title":"Elevation of AKR7A2 (succinic semialdehyde reductase) in neurodegenerative disease","volume":"916","author":"Picklo","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib112","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/taap.2002.9506","article-title":"Carbonyl toxicology and Alzheimer's disease","volume":"184","author":"Picklo","year":"2002","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib114","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.abb.2004.02.002","article-title":"Characterization of a class alpha glutathione-S-transferase with glutathione peroxidase activity in human liver microsomes","volume":"424","author":"Prabhu","year":"2004","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"10.1016\/j.pharmthera.2007.03.015_bib115","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1021\/tx990034o","article-title":"Covalent modifications to 2'-deoxyguanosine by 4-oxo-2-nonenal, a novel product of lipid peroxidation","volume":"12","author":"Rindgen","year":"1999","journal-title":"Chem Res Toxicol"},{"issue":"41","key":"10.1016\/j.pharmthera.2007.03.015_bib116","doi-asserted-by":"crossref","first-page":"42351","DOI":"10.1074\/jbc.R400019200","article-title":"Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes","volume":"279","author":"Robertson","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib117","doi-asserted-by":"crossref","first-page":"11632","DOI":"10.1016\/S0021-9258(18)99004-6","article-title":"The antioxidant response element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity","volume":"266","author":"Rushmore","year":"1991","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib118","first-page":"43","article-title":"Psychophysiological research in psychiatry and neuropsychopharmacology. II. The investigation of antihypoxidotic\/nootropic drugs (tenilsetam and co-dergocrine-mesylate) in elderlies with the Viennese Psychophysiological Test-System (VPTS)","volume":"11","author":"Saletu","year":"1989","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.pharmthera.2007.03.015_bib119","first-page":"2355","article-title":"Methylglyoxal-derived modifications in lens aging and cataract formation","volume":"39","author":"Shamsi","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.taap.2005.09.017","article-title":"Metabolism of trans, trans-muconaldehyde, a cytotoxic metabolite of benzene, in mouse liver by alcohol dehydrogenase Adh1 and aldehyde reductase AKR1A4","volume":"210","author":"Short","year":"2006","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4-5","key":"10.1016\/j.pharmthera.2007.03.015_bib121","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0098-2997(03)00011-6","article-title":"Intracellular metabolism of 4-hydroxynonenal","volume":"24","author":"Siems","year":"2003","journal-title":"Mol Aspects Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib122","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1113\/expphysiol.1997.sp004024","article-title":"Oxidative stress: oxidants and antioxidants","volume":"82","author":"Sies","year":"1997","journal-title":"Exp Physiol"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib123","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0009-2797(02)00174-6","article-title":"Transient induction of increased aldehyde dehydrogenase 3A1 levels in cultured human breast (adeno)carcinoma cell lines via 5\u2032-upstream xenobiotic, and electrophile, responsive elements is, respectively, estrogen receptor-dependent and -independent","volume":"143\u2013144","author":"Sladek","year":"2003","journal-title":"Chem Biol Interact"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.03.015_bib124","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1046\/j.1471-4159.1995.64062660.x","article-title":"Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease","volume":"64","author":"Smith","year":"1995","journal-title":"J Neurochem"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.03.015_bib125","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/oxfordjournals.jbchem.a021864","article-title":"Ah receptor, a novel ligand-activated transcription factor","volume":"122","author":"Sogawa","year":"1997","journal-title":"J Biochem (Tokyo)"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib126","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1006\/bbrc.1996.1386","article-title":"4-hydroxy-2,3-trans-nonenal induces transcription and expression of aldose reductase","volume":"226","author":"Spycher","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib127","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1096\/fasebj.11.2.9039961","article-title":"Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells","volume":"11","author":"Spycher","year":"1997","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.03.015_bib129","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1006\/bbrc.1995.2835","article-title":"Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase","volume":"217","author":"Srivastava","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt3","key":"10.1016\/j.pharmthera.2007.03.015_bib128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1042\/bj3290469","article-title":"Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal","volume":"329","author":"Srivastava","year":"1998","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/oxfordjournals.jbchem.a021944","article-title":"Overexpression of aldehyde reductase protects PC12 cells from the cytotoxicity of methylglyoxal or 3-deoxyglucosone","volume":"123","author":"Suzuki","year":"1998","journal-title":"J Biochem"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.03.015_bib131","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1291\/hypres.24.365","article-title":"The aldehyde dehydrogenase 2 gene is a risk factor for hypertension in Japanese but does not alter the sensitivity to pressor effects of alcohol: the Suita study","volume":"24","author":"Takagi","year":"2001","journal-title":"Hypertens Res"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.03.015_bib132","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1291\/hypres.25.677","article-title":"Aldehyde dehydrogenase 2 gene is a risk factor for myocardial infarction in Japanese men","volume":"25","author":"Takagi","year":"2002","journal-title":"Hypertens Res"},{"issue":"18","key":"10.1016\/j.pharmthera.2007.03.015_bib133","first-page":"5196","article-title":"Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray","volume":"62","author":"Thimmulappa","year":"2002","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.03.015_bib134","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0306-3623(95)02054-3","article-title":"Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-a role in pathogenesis and antiproliferative chemotherapy","volume":"27","author":"Thornalley","year":"1996","journal-title":"Gen Pharmacol"},{"issue":"Pt 6","key":"10.1016\/j.pharmthera.2007.03.015_bib135","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1042\/bst0311343","article-title":"Glyoxalase I-structure, function and a critical role in the enzymatic defence against glycation","volume":"31","author":"Thornalley","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pharmthera.2007.03.015_bib136","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1196\/annals.1333.014","article-title":"Dicarbonyl intermediates in the maillard reaction","volume":"1043","author":"Thornalley","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2007.03.015_bib137","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/0264-6021:3440109","article-title":"Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose","volume":"344","author":"Thornalley","year":"1999","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.03.015_bib138","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.HYP.0000138070.47616.9d","article-title":"Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?","volume":"44","author":"Touyz","year":"2004","journal-title":"Hypertension"},{"issue":"1-3","key":"10.1016\/j.pharmthera.2007.03.015_bib139","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0009-2797(00)00270-2","article-title":"Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells","volume":"130-132","author":"Townsend","year":"2001","journal-title":"Chem Biol Interact"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.03.015_bib140","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1089\/ars.2000.2.4-681","article-title":"Serum 4-hydroxy-2-nonenal-modified albumin is elevated in patients with type 2 diabetes mellitus","volume":"2","author":"Toyokuni","year":"2000","journal-title":"Antioxid Redox Signal"},{"issue":"26","key":"10.1016\/j.pharmthera.2007.03.015_bib141","doi-asserted-by":"crossref","first-page":"16058","DOI":"10.1074\/jbc.273.26.16058","article-title":"Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins","volume":"273","author":"Uchida","year":"1998","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.03.015_bib142","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1568007054038238","article-title":"The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders","volume":"4","author":"van Muiswinkel","year":"2005","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"7","key":"10.1016\/j.pharmthera.2007.03.015_bib143","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1016\/S0021-9258(18)42844-X","article-title":"Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications","volume":"267","author":"Vander Jagt","year":"1992","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib144","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0167-4838(95)00021-L","article-title":"Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate","volume":"1249","author":"Vander Jagt","year":"1995","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1081\/DMR-120034001","article-title":"Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism","volume":"36","author":"Vasiliou","year":"2004","journal-title":"Drug Metab Rev"},{"issue":"Pt 18","key":"10.1016\/j.pharmthera.2007.03.015_bib146","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1242\/jeb.01022","article-title":"Oxidants, antioxidants and the ischemic brain","volume":"207","author":"Warner","year":"2004","journal-title":"J Exp Biol"},{"issue":"1-2","key":"10.1016\/j.pharmthera.2007.03.015_bib147","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF03033780","article-title":"The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal","volume":"7","author":"Webster","year":"2005","journal-title":"Neurotox Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib148","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0009-2797(84)90076-0","article-title":"The mechanism of action of 4-hydroxynonenal in cell injury","volume":"52","author":"White","year":"1984","journal-title":"Chem Biol Interact"},{"issue":"8","key":"10.1016\/j.pharmthera.2007.03.015_bib149","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neurobiolaging.2005.06.004","article-title":"Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease","volume":"27","author":"Williams","year":"2006","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.03.015_bib150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0891-5849(89)90137-8","article-title":"Biological interactions of alpha,beta-unsaturated aldehydes","volume":"7","author":"Witz","year":"1989","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib151","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.brainres.2006.04.038","article-title":"Neurotoxicity of reactive aldehydes: the concept of \u201caldehyde load\u201d as demonstrated by neuroprotection with hydroxylamines","volume":"1095","author":"Wood","year":"2006","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.03.015_bib152","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1139\/Y05-137","article-title":"Is methylglyoxal a causative factor for hypertension development?","volume":"84","author":"Wu","year":"2006","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.03.015_bib153","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2003.12.023","article-title":"Glutathione-S-transferase A4-4 modulates oxidative stress in endothelium: possible role in human atherosclerosis","volume":"173","author":"Yang","year":"2004","journal-title":"Atherosclerosis"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725807000824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725807000824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T06:41:59Z","timestamp":1628836919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725807000824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":155,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0163725807000824"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2007.03.015","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}